These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29176885)

  • 1. Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography.
    Aoyama R; Takano H; Kobayashi Y; Kitamura M; Asai K; Amano Y; Kumita SI; Shimizu W
    PLoS One; 2017; 12(11):e0188479. PubMed ID: 29176885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study.
    Uehara T; Ishida Y; Hayashida K; Shimonagata T; Miyake Y; Sago M; Oka H; Nagata S; Miyatake K; Nishimura T
    Ann Nucl Med; 1998 Apr; 12(2):95-103. PubMed ID: 9637280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
    Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
    Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial metabolic changes in hypertrophic cardiomyopathy.
    Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
    J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
    Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
    Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Myocardial Metabolic Abnormalities by 18F-FDG PET/CT and Corresponding Pathological Changes in Beagles with Local Heart Irradiation.
    Yan R; Song J; Wu Z; Guo M; Liu J; Li J; Hao X; Li S
    Korean J Radiol; 2015; 16(4):919-28. PubMed ID: 26175594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Takotsubo cardiomyopathy: FDG myocardial uptake pattern in fasting patients. Comparison of PET/CT, SPECT, and ECHO results.
    Kobylecka M; Budnik M; Kochanowski J; Piatkowski R; Chojnowski M; Fronczewska-Wieniawska K; Mazurek T; Maczewska J; Peller M; Opolski G; Krolicki L
    J Nucl Cardiol; 2018 Aug; 25(4):1260-1270. PubMed ID: 28054182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of pulmonary obstruction on myocardial functioning: a pilot study using multiple time-point 18F-FDG-PET imaging.
    Choi GG; Han Y; Weston B; Ciftci E; Werner TJ; Torigian D; Salavati A; Alavi A
    Nucl Med Commun; 2015 Jan; 36(1):78-83. PubMed ID: 25279708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial blood flow and metabolism in patients with hypertrophic cardiomyopathy--a study with carbon-11 acetate and positron emission tomography.
    Ishiwata S; Maruno H; Senda M; Toyama H; Nishiyama S; Seki A
    Jpn Circ J; 1997 Mar; 61(3):201-10. PubMed ID: 9152767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.
    Hasegawa K; Fujiwara H; Doyama K; Miyamae M; Fujiwara T; Suga S; Mukoyama M; Nakao K; Imura H; Sasayama S
    Circulation; 1993 Aug; 88(2):372-80. PubMed ID: 8339400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of myocardial fluoro-18 2-deoxyglucose uptake in patients with apical hypertrophic cardiomyopathy.
    Shiba N; Kagaya Y; Ishide N; Otani H; Takeyama D; Yamane Y; Chida M; Ikeda J; Ido T; Shirato K
    Jpn Circ J; 1997 Mar; 61(3):223-30. PubMed ID: 9152770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.